This article examines the adoption of the ventilator bundle elements to prevent adverse events in ventilated patients (including ventilator-associated pneumonia, or VAP); the effectiveness of individual elements and setting characteristics in reducing VAP; the effectiveness of two infection-specific elements on reducing VAP; and the crossover effects of complying with VAP elements on central line-associated bloodstream infections.